Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase
Sublingual troches: Typical dose: 50-200mcg per troche Frequency: 1-2 times daily Administration: Dissolve between cheek and gum for 15-20 minutes Absorption: Bypasses first-pass liver metabolism through oral mucosa Liposomal oral: Typical dose: 100-500mcg Frequency: Once daily Note: Lipid encapsulation protects peptide through digestion Oral forms suit those unwilling to inject who still want systemic rather than purely local effects
Neurology of Nutritional Vitamin B12 Deficiency in Infants: Case Series From India and Literature Review. J Child Neurol
Megadoses of B12 can lead to headaches, nausea, diarrhea, vomiting, and flushing, he says
Wolverine Blend peptide therapy may be discussed with eligible men and women who are interested in recovery-focused wellness care
No, BPC-157 is not approved by the FDA for human use in the United States and is considered unlicensed in the European Union